In the urine samples, Abdelsameea et al. quantified NGAL concentrations using ELISA and found that urinary NGAL levels increased with the progression of the disease from normal to chronic hepatitis to liver cirrhosis and HCC. The gene discussed is LCN2; the disease is hepatocellular carcinoma.